Work

First-in-human trial of microRNA cancer therapy with MRX34, a liposomal miR-34 mimic: Phase Ia expansion in patients with advanced solid tumors.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.tps2597

Authors: Muhammad Shaalan Beg, David S. Hong, Jasgit C. Sachdev, Andrew Jacob Brenner, Mitesh J. Borad, Ho Yeong Lim, Tae-You Kim, Carlos Becerra, Keunchil Park, Andreas G. Bader, Jay Stoudemire, Susan Smith, Sinil Kim, Yoon-Koo Kang

Institutions: The University of Texas Southwestern Medical Center, The University of Texas MD Anderson Cancer Center, The University of Texas at San Antonio Health Science Center, Mayo Clinic in Arizona, Samsung Medical Center, Sungkyunkwan University, Seoul National University, Seoul National University Hospital, Mirna Therapeutics (United States), Asan Medical Center, University of Ulsan

Language: English

Topic: MicroRNA in disease regulation

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2780566941

Cites:

Cited by: 10

Related to: 10